469 related articles for article (PubMed ID: 16130614)
1. Platelet alloimmunization in multitransfused patients with haemato-oncological disorders.
Bajpai M; Kaura B; Marwaha N; Kumari S; Sharma RR; Agnihotri SK
Natl Med J India; 2005; 18(3):134-6. PubMed ID: 16130614
[TBL] [Abstract][Full Text] [Related]
2. [Platelet alloimmunization in patients with oncologic blood disorders treated with multiple transfusions: prospective study in adults and children].
Pereira J; Bronfman L; Bertín P; Marzouka E; Hidalgo P; Amaya S; Mezzano D
Rev Med Chil; 1997 Nov; 125(11):1305-12. PubMed ID: 9609051
[TBL] [Abstract][Full Text] [Related]
3. [Demonstration of platelet-specific alloantibodies in HLA-sensitized hematologic oncologic patients].
Schnaidt M; Wernet D; Mayer G; Northoff H
Beitr Infusionsther Transfusionsmed; 1994; 32():240-3. PubMed ID: 9480099
[TBL] [Abstract][Full Text] [Related]
4. [Platelet transfusion refractoriness and effective management of platelet alloimmunization].
Amemiya Y
Nihon Rinsho; 1997 Sep; 55(9):2392-8. PubMed ID: 9301306
[TBL] [Abstract][Full Text] [Related]
5. Incidence of transfusion-induced platelet-reactive antibodies evaluated by specific assays for the detection of human leucocyte antigen and human platelet antigen antibodies.
Fontão-Wendel R; Silva LC; Saviolo CB; Primavera B; Wendel S
Vox Sang; 2007 Oct; 93(3):241-9. PubMed ID: 17845262
[TBL] [Abstract][Full Text] [Related]
6. Platelet alloimmunization after long-term red cell transfusion in transfusion-dependent thalassemia patients.
Lo SC; Chang JS; Lin SW; Lin DT
Transfusion; 2005 May; 45(5):761-5. PubMed ID: 15847666
[TBL] [Abstract][Full Text] [Related]
7. Alloimmunization following platelet transfusions in patients with acute nonlymphocytic leukemia.
Nozaki H; Shimizu M; Komatsuda M; Watanabe K; Nagao T; Arimori S
Tokai J Exp Clin Med; 1986 Aug; 11(3):201-4. PubMed ID: 3475819
[TBL] [Abstract][Full Text] [Related]
8. Flow cytometric platelet cross-matching to predict platelet transfusion in acute leukemia.
Sayed D; Bakry R; El-Sharkawy N; Zahran A; Khalaf MR
J Clin Apher; 2011; 26(1):23-8. PubMed ID: 21312256
[TBL] [Abstract][Full Text] [Related]
9. [Analysis of anti-platelet antibodies using flow cytometry].
Tsubaki K
Rinsho Byori; 1993 Sep; 41(9):998-1006. PubMed ID: 8254978
[TBL] [Abstract][Full Text] [Related]
10. Platelet transfusion refractoriness.
Hod E; Schwartz J
Br J Haematol; 2008 Jul; 142(3):348-60. PubMed ID: 18510692
[TBL] [Abstract][Full Text] [Related]
11. HPA antibodies in Algerian multitransfused patients: Prevalence and involvement in platelet refractoriness.
Brouk H; Bertrand G; Zitouni S; Djenouni A; Martageix C; Griffi F; Kaplan C; Ouelaa H
Transfus Apher Sci; 2015 Jun; 52(3):295-9. PubMed ID: 25620758
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy of leukocyte-depleted platelet concentrates for prevention of HLA-alloimmunization in patients with frequent platelet transfusions: a prospective multi-institutional study using a polyester platelet filter].
Handa M; Ikeda Y; Kurata Y; Tsubaki K; Horiuchi A; Furihata K; Kimura Y; Toyama K; Takamoto S; Tsukimoto I
Rinsho Ketsueki; 1992 Apr; 33(4):451-60. PubMed ID: 1602608
[TBL] [Abstract][Full Text] [Related]
13. Specificities of anti-platelet antibodies in multitransfused patients with haemato-oncological disorders.
Kurz M; Greinix H; Höcker P; Kalhs P; Knöbl P; Mayr WR; Pober M; Panzer S
Br J Haematol; 1996 Dec; 95(3):564-9. PubMed ID: 8943903
[TBL] [Abstract][Full Text] [Related]
14. Platelet transfusions are associated with the development of anti-major histocompatibility complex class I antibodies in patients with left ventricular assist support.
Moazami N; Itescu S; Williams MR; Argenziano M; Weinberg A; Oz MC
J Heart Lung Transplant; 1998 Sep; 17(9):876-80. PubMed ID: 9773859
[TBL] [Abstract][Full Text] [Related]
15. Platelet and granulocyte alloimmunisation in multitransfused Tunisian patients.
Skouri H; Bettaieb A; Fromont P; Elomri H; Ennabli S; Bierling P
Eur J Haematol; 2005 Sep; 75(3):248-51. PubMed ID: 16104882
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity of antibody response to human platelet transfusion.
Wu KK; Thompson JS; Koepke JA; Hoak JC; Flink R
J Clin Invest; 1976 Aug; 58(2):432-8. PubMed ID: 956376
[TBL] [Abstract][Full Text] [Related]
17. Alloimmunization to public HLA antigens in multi-transfused platelet recipients.
MacPherson BR; Hammond PB; Maniscalco CA
Ann Clin Lab Sci; 1986; 16(1):38-44. PubMed ID: 3947028
[TBL] [Abstract][Full Text] [Related]
18. The role of pathogen-reduced platelet transfusions on HLA alloimmunization in hemato-oncological patients.
Saris A; Kerkhoffs JL; Norris PJ; van Ham SM; Ten Brinke A; Brand A; van der Meer PF; Zwaginga JJ
Transfusion; 2019 Feb; 59(2):470-481. PubMed ID: 30499599
[TBL] [Abstract][Full Text] [Related]
19. Management of patients with hematologic malignancies and aplastic anemia who are refractory to platelet transfusions.
Sandler SG
Haematologia (Budap); 1998; 29(1):1-11. PubMed ID: 9704252
[TBL] [Abstract][Full Text] [Related]
20. Incidence and specificity of HLA antibodies in multitransfused patients with acquired aplastic anemia.
Laundy GJ; Bradley BA; Rees BM; Younie M; Hows JM
Transfusion; 2004 Jun; 44(6):814-25. PubMed ID: 15157245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
